IRIS
ORIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.463
EU - Europa 11.142
AS - Asia 3.872
SA - Sud America 664
Continente sconosciuto - Info sul continente non disponibili 62
AF - Africa 37
OC - Oceania 23
Totale 37.263
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.384
RU - Federazione Russa 3.450
UA - Ucraina 2.802
VN - Vietnam 1.558
GB - Regno Unito 1.198
SE - Svezia 1.112
SG - Singapore 1.008
DE - Germania 994
CN - Cina 937
BR - Brasile 594
FR - Francia 577
IT - Italia 418
FI - Finlandia 286
KR - Corea 127
PL - Polonia 118
EU - Europa 62
IN - India 51
CA - Canada 46
HK - Hong Kong 33
NL - Olanda 32
IQ - Iraq 26
BE - Belgio 25
AT - Austria 22
BD - Bangladesh 22
AR - Argentina 20
AU - Australia 19
MX - Messico 18
IE - Irlanda 16
SA - Arabia Saudita 14
JP - Giappone 13
TR - Turchia 13
VE - Venezuela 13
ES - Italia 12
EC - Ecuador 11
ZA - Sudafrica 11
DK - Danimarca 10
UZ - Uzbekistan 10
CO - Colombia 8
BG - Bulgaria 7
CZ - Repubblica Ceca 7
PK - Pakistan 7
EG - Egitto 6
LV - Lettonia 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
HR - Croazia 5
HU - Ungheria 5
ID - Indonesia 5
IL - Israele 5
MA - Marocco 5
PA - Panama 5
PT - Portogallo 5
PY - Paraguay 5
BH - Bahrain 4
BY - Bielorussia 4
KE - Kenya 4
LT - Lituania 4
NZ - Nuova Zelanda 4
OM - Oman 4
RS - Serbia 4
JO - Giordania 3
LU - Lussemburgo 3
MM - Myanmar 3
NO - Norvegia 3
RO - Romania 3
TN - Tunisia 3
TW - Taiwan 3
UY - Uruguay 3
BN - Brunei Darussalam 2
CL - Cile 2
CY - Cipro 2
EE - Estonia 2
IM - Isola di Man 2
IR - Iran 2
ME - Montenegro 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AL - Albania 1
BB - Barbados 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
GI - Gibilterra 1
GL - Groenlandia 1
GN - Guinea 1
GR - Grecia 1
HT - Haiti 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
Totale 37.250
Salva come PNG Salva come JPEG
Città #
Fairfield 2.739
Woodbridge 2.587
Houston 1.971
Dong Ket 1.474
Ann Arbor 1.448
Ashburn 1.372
Chandler 1.364
Wilmington 1.311
Seattle 1.085
Dallas 1.000
Cambridge 933
Dearborn 890
Jacksonville 776
Southend 630
Nyköping 614
Boardman 472
Moscow 426
Singapore 425
Beijing 366
Lawrence 258
Princeton 258
Ogden 178
Düsseldorf 137
Shanghai 127
Des Moines 113
Kraków 108
Los Angeles 100
Yubileyny 90
San Diego 88
Bremen 75
The Dalles 71
Grafing 66
Nanjing 62
Jinan 55
London 53
New York 48
São Paulo 48
Hefei 40
Chicago 32
Ho Chi Minh City 32
Hong Kong 29
Edinburgh 28
Norwalk 28
Shenyang 27
Helsinki 26
Brussels 25
Kunming 24
Munich 24
San Mateo 24
Napoli 21
Nanchang 20
Santa Clara 20
Rome 19
Amsterdam 18
Auburn Hills 18
Guangzhou 18
Hanover 17
Council Bluffs 16
Hanoi 16
Mirabella Eclano 16
Taiyuan 16
Zhengzhou 16
Phoenix 15
Hangzhou 14
Kilburn 14
Montreal 14
Rio de Janeiro 14
Belo Horizonte 13
Boston 13
Brooklyn 13
Curitiba 13
Hebei 13
Atlanta 12
Columbus 12
Saint Petersburg 12
Vienna 12
Baghdad 11
Chennai 11
Dublin 11
Falls Church 11
Hounslow 11
Tianjin 11
Tokyo 11
Acton 10
Changsha 10
Fuzhou 10
Montemiletto 10
Naples 10
Porto Alegre 10
Riyadh 10
San Francisco 10
Copenhagen 9
Frankfurt am Main 9
Nuremberg 9
Seongnam-si 9
Stockholm 9
Tashkent 9
Warsaw 9
Brasília 8
Campinas 8
Totale 24.808
Salva come PNG Salva come JPEG
Nome #
Il microinfusore: quali indicazioni e quando iniziare 450
Sussidio didattico per gli studenti di igiene generale e applicata per il corso di laurea in scienze del servizio sociale 307
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 277
Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity 252
The good and bad effects of statins on insulin sensitivity and secretion 239
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. 225
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 222
Cardiopulmonary impairment in young women with polycystic ovary syndrome. 221
Secrezioni ormonali ectopiche 219
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. 210
Effects of physical exercise on the female reproductive system. 203
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. 201
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance 199
Vitamin D and thyroid disease: to D or not to D? 199
Cardiological aspects of growth hormone and insulin-like growth factor-I. 198
Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside. 198
A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. 195
Endocrine secretions under abnormal light-dark cycles and in the blind. 192
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. 192
The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome 192
Adiponectin levels in women with polycystic ovary syndrome 191
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 189
Failure of long-term therapy with sodium valproate in Cushing's disease. 189
Adrenal mass: insight into pathogenesis and a common link with insulin resistance. 189
Height, weight, height velocity of primary school population sample in Campania region. 188
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. 188
Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome? 186
Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood and quality of life 185
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 185
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept. 185
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 185
Effects of neridronate treatment in elderly women with osteoporosis 182
THE IMPACT OF PROBAND GLUCOSE TOLERANCE STATUS ON BODY MASS INDEX (BMI) AND ADIPOSITY IN ADOLESCENT GIRLS AT HIGH RISK FOR POLYCYSTIC OVARY SYNDROME (PCOS) 182
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 182
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 182
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women. 181
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. 181
Lifestyle changes in the management of adulthood and childhood obesity. 180
Ovulation induction in polycystic ovary syndrome 179
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine. 179
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 178
Effect of growth hormone on cardiac function. 177
Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005 177
The increase of leukocytes as a new putative marker of low- grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome 177
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. 177
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. 177
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review 176
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. 176
Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens. 175
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 175
Current evidence on vitamin D deficiency and kidney transplant: What’s new? 175
Auditory brainstem responses in thyroid diseases before and after therapy. 174
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin 174
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 174
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women 173
GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding. 173
Liver-spleen axis, Insulin-like Growth Factor-(IGF)-I axis and fat mass in overweight/obese females 173
Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age 172
Endothelial dysfunction in PCOS: role of obesity and adipose hormones. 172
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 172
Adrenocortical tumors and insulin resistance. What is the first step? 172
Prevalence of polycystic ovary morphology in a region of South Italy. 172
Growth hormone status in morbidly obese subjects and correlation with body composition 171
Circulating ghrelin concentrations in the polycystic ovary syndrome 171
Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. 171
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 171
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology. 171
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 171
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 170
Bisphenol A in Polycystic Ovary Syndrome and its Association with Liver-Spleen Axis. 170
Terapia di associazione con insulina ed analoghi del GLP-1 170
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis. 169
Does raloxifene inhibit the growth of uterine fibroids? 168
Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study 167
Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response 167
Is the ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? 166
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors 166
Antisperm antibodies in cryptorchidism before and after surgery. 165
Lymphocyte subset pattern in acromegaly. 165
Cardiovascular risk of women with polycystic ovary syndrome 165
Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis 164
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 164
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS 164
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome 164
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. 163
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 163
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 163
Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study 163
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS) 162
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 162
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women 162
Anti-proliferative and pro-apoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women 161
Evidence for altered adipocyte function in polycystic ovary syndrome. 160
Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. 160
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome 159
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study. 159
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome. 158
Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin. 158
Gut: a key player in the pathogenesis of type 2 diabetes? 158
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome:A Prospective Parallel Randomized Double-Blind Placebo-Controlled Trial 157
Totale 18.378
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.911
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.953 0 0 0 184 618 96 525 37 124 440 129 1.800
2021/20222.163 139 314 34 771 76 45 253 199 141 116 69 6
2022/20234.290 523 136 215 458 498 796 115 566 571 120 223 69
2023/20241.231 134 71 77 54 54 34 25 316 268 56 12 130
2024/20255.948 86 505 15 133 86 499 1.693 2.000 322 199 205 205
2025/20261.883 491 820 523 49 0 0 0 0 0 0 0 0
Totale 37.691